Video Experimental Relacionado
Updated: Jun 30, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
La experiencia del entrenamiento cognitivo basado en procesos en personas con enfermedad de Parkinson: una ruta para
Lois Walton1, Anna Stigsdotter Neely2, David Bäckström3
1Department of Social and Psychological Sciences, Karlstad University; Karlstad, Sweden.
Neuropsychological rehabilitation
|February 10, 2026
Resumen
El entrenamiento cognitivo (ET) para pacientes con enfermedad de Parkinson (EP) se experimenta de manera activa y reflexiva. Los desafíos durante la TC son cruciales para la transferencia de habilidades a la vida cotidiana.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Psicología Psicología Psicología.
- La rehabilitación es la rehabilitación.
Sus antecedentes:
- Los metanálisis indican que el entrenamiento cognitivo (ET) mejora la cognición en la enfermedad de Parkinson (EP).
- La TC se recomienda para la EP con deterioro cognitivo leve.
- Existe una investigación limitada sobre la experiencia vivida de la TC en pacientes con EP.
Objetivo del estudio:
- Explorar la experiencia de TC basada en procesos en personas con EP.
- Comprender cómo los participantes se involucraron y utilizaron la TC en la vida diaria.
Principales métodos:
- Entrevistas individuales semi-estructuradas con 18 participantes en el PD que completaron 6-8 semanas de TC.
- Los datos se analizan utilizando el análisis temático reflexivo.
Principales resultados:
- Surgieron tres temas: dedicación a la TC, cambios cognitivos percibidos durante el entrenamiento e inspiración para transferir habilidades.
- Se identificó una ruta de transferencia que involucra experiencias emocionales y motivacionales.
Conclusiones:
- La TC es un proceso activo y reflexivo para los pacientes con EP.
- Superar los desafíos emocionales y cognitivos durante la TC es clave para la transferencia de habilidades en el mundo real.
- La investigación futura debe correlacionar los hallazgos cualitativos con los resultados cuantitativos.
Videos de Conceptos Relacionados
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...